MedTrace Logo

Breast Study to Determine the Ability of Non-Invasive Optical Transillumination Spectroscopy to Predict Breast Density.

NCT00188682 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2007-11-15

No results posted yet for this study

Summary

The purpose of this study is to learn more about the application of transillumination measurements in the determination of breast cancer risk. The goal is to demonstrate a correlation between non-invasive optical transillumination spectroscopy and parenchymal density pattern.

Conditions

Sponsors & Collaborators

  • United States Department of Defense

    collaborator FED

  • University Health Network, Toronto

    lead OTHER

Principal Investigators

  • Lothar Lilge, PhD · Ontario Cancer Institute, University Health Network, Toronto, Ontario, Canada M5G 2M9; Department of Biophysics and Bioimaging, University of Toronto, Toronto, Ontario, Canada M5G 2M9

Eligibility

Min Age
35 Years
Max Age
75 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2000-03-31
Completion
2003-09-30

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00188682 on ClinicalTrials.gov